Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrochlorothiazide after ESWL for renal pelvic stones
IRCT20171104037212N2Phase 3Completed
- Sponsor
- Rafsanjan University of Medical Sciences
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of hydrochlorothiazide in nephrolithiasis (2 arms), sponsored by Rafsanjan University of Medical Sciences. Primary endpoint: Stone free duration. Started Nov 2017; status: completed.
02
Drugs
hydrochlorothiazide
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on IRCT20171104037212N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171104037212N2.